Health
Family businesses demonstrate greater resilience than non-family firms during the Covid-19 pandemic due to their patient capital, social responsibility and accelerated business transformation, but the crisis has brought home the need for families to formalise and communicate their succession plans.
Covid-19, Brexit, Black Lives Matter, climate change and the threats to US democracy have created a once in a lifetime opportunity for family next generations to cultivate their “grit”, says a leading family clinical and consulting psychotherapist.
Vertical farming is being planted as the future of agriculture and the blossoming sector’s long-term growth could be a good fit for family investors and their patient capital.
The Covid-19 pandemic and its social and economic reverberations are triggering particularly salient challenges for family businesses. The first one relates to family business succession.
Devices to beat hospital-acquired infections, prevent opioid overdoses and instantly spot infections in blood are among the pioneering healthcare innovations being showcased to family investors at the upcoming MedTech Investing Europe Conference in Lausanne.
How is one Chinese biotechnology group succeeding in supporting the earliest stage of new drug discovery when global pharmaceutical companies have given up? Dr Jun Mao, founder and chairwoman of Viva Ventures, explains how it leverages its in-house expertise to invest in hundreds of biotech startups in the $20 trillion global pharmaceutical and biotechnology market.
Editor's Pick